Avastin/Lucentis Update 51: And, the Dam Breaks!

After reporting on the news out of England earlier this week (Update 50), I have been waiting for the “other shoe” to drop – and it just has, as reported by InPharm this morning (as tweeted by RetinaToday). Here is the story found on the InPharm website:

Novartis cuts Lucentis price amid growing pressure

Published on 10/07/11 at 10:15am

Novartis has been forced to cut the Swiss price of its eye drug Lucentis by 30% after sharp negotiations with the government. The deal was negotiated by Switzerland's Health Minister Didier Burkhalter and could save the country (Read more...)

Full Story →